Investigating the response to intravenous iron in restless legs syndrome: An observational study

Sleep Medicine

Volumn 13, Issue 6, 2012, Pages 732-735

  Hornyak, Magdolna ^a,b   Scholz, Hanna ^a   Kiemen, Andrea ^a   Kassubek, Jan ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Intravenous iron; Iron deficiency; Observational study; Responder; Restless legs syndrome; Treatment

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SINGLE DRUG DOSE; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ADULT; AGED; COMORBIDITY; FEMALE; FERRIC COMPOUNDS; FERRITINS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; MALE; MALTOSE; MIDDLE AGED; PROSPECTIVE STUDIES; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84861945871     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2012.02.011     Document Type: Article

References (12)

1. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4(2):101-119. International Restless Legs Syndrome Study Group.
2. García-Borreguero D., Allen R.P., Kohnen R., Högl B., Trenkwalder C., Oertel W., et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 2007, 8(5):520-530. International Restless Legs Syndrome Study Group.
3. Earley C.J., Heckler D., Allen R.P. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 2004, 5(3):231-235.
4. Grote L., Leissner L., Hedner J., Ulfberg J. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Mov Disord 2009, 24(10):1445-1452.
5. Trenkwalder C., Högl B., Benes H., Kohnen R. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med 2008, 9(5):572-574.
6. Frauscher B., Gschliesser V., Brandauer E., El-Demerdash E., Kaneider M., Rücker L., et al. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels. Sleep Med 2009, 10(6):611-615.
7. Wang J., O'Reilly B., Venkataraman R., Mysliwiec V., Mysliwiec A. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study. Sleep Med 2009, 10(9):973-975.
8. Earley C.J., Horska A., Mohamed M.A., Barker P.B., Beard J.L., Allen R.P. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2009, 10(2):206-211.
9. Allen R.P., Adler C.H., Du W., Butcher A., Bregman D.B., Earley C.J. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. Sleep Med 2011, 12(9):906-913.
10. Walters A.S., LeBrocq C., Dhar A., Hening W., Rosen R., Allen R.P., et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003, 4(2):121-132. International Restless Legs Syndrome Study Group.
11. Farrar J.T., Young J.P., LaMoreaux L., Werth J.L., Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001, 94(2):149-158.
12. Escobar J.I., Cook B., Chen C.N., Gara M.A., Alegría M., Interian A., et al. Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations. J Psychosom Res 2010, 69(1):1-8.